Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06027294 · ClinicalTrials.gov registry record · NA

Blood Flow Regulation and Neuromuscular Function Post-Stroke

A NA study of Stroke, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06027294 is a NA study of Stroke that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 40 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06027294, a NA study of Stroke, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The muscles of stroke survivors can fatigue faster compared to muscles in people who have not had a stroke, which can limit how long a person with stroke can perform tasks such as walking. This study will examine how blood flow is regulated to the exercising leg muscle post-stroke, because if the muscle does not receive enough blood flow it will become fatigued. Finally, the investigators will use a safe and simple non-invasive intervention called ischemic conditioning, which has known effects to improve blood flow to exercising muscle and determine the effects on muscle fatigue.

Conditions Studied

Interventions

  • PROCEDURE Ischemic Conditioning

Study Locations (2)

Wisconsin

  • Medical College of Wisconsin - Milwaukee
  • Marquette University - Milwaukee

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-01-11
Est. Completion 2028-06-30
Phase NA

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT06027294

The ClinicalTrials.gov registry entry for NCT06027294 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Ischemic Conditioning is the first listed.

NCT06027294 reports 2 study locations spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06027294 about?

NCT06027294 is a clinical study titled "Blood Flow Regulation and Neuromuscular Function Post-Stroke". The muscles of stroke survivors can fatigue faster compared to muscles in people who have not had a stroke, which can limit how long a person with stroke can perform tasks such as walking. This study will examine how blood flow is regulated to the exercising leg muscle post-stroke, because if the mu...

What is the current status of trial NCT06027294?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-01-11. Estimated completion is 2028-06-30.

What conditions does trial NCT06027294 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06027294?

The interventions under investigation include: Ischemic Conditioning (PROCEDURE).

Who is sponsoring clinical trial NCT06027294?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06027294 being conducted?

This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.